Investors
Don't miss any news, subscribe to our press releases.
Annual General Meeting 2021
Annual General Meeting of Sprint Bioscience AB (publ)
(The full text of the invitation can be found in Press releases and as a PDF on this page)
The shareholders of Sprint Bioscience AB (publ), corporate identity number 556789-7557 ("Sprint Bioscience" or "The company), are hereby invited to the Annual General Meeting on Wednesday 12 May 2021.
In light of the risk of spreading Covid-19 and the authorities' regulations and advice on avoiding gatherings, the Board of Directors has decided, on the basis of temporary legal provisions, that the Annual General Meeting will be conducted without physical presence by shareholders exercising their voting rights only by postal voting.
Answers to any questions from shareholders that may be received in advance by post or e-mail will be available at the Company and on the Company's website, www.sprintbioscience.com under the heading "Annual General Meeting 2021", no later than Thursday 29 April 2021. All questions received will be answered in accordance with the instructions under the heading "Shareholders' right to request information" below.
Information on the resolutions adopted by the Annual General Meeting will be published on 12 May 2021 through a press release.
Right to participate in the General Meeting
Shareholders wishing to attend the Annual General Meeting shall:
- be entered in the share register maintained by Euroclear Sweden AB no later than Tuesday 4 May 2021, and
- notify their participation no later than Tuesday 11 May 2021 by submitting a complete postal voting form and, where applicable, proxies, registration certificates and other corresponding authorisation documents in accordance with the instructions under the heading "Information on postal voting" below
Shareholders whose shares are registered in the name of a nominee through a bank or securities institution must temporarily re-register the shares in their own name in order to be entitled to participate in the meeting. Such registration must be completed at Euroclear Sweden AB on Thursday 6 May 2021, which means that the shareholder must inform the nominee well in advance of this date.
Information on postal voting
Due to the outbreak of the coronavirus causing Covid-19 and the safety of the shareholders, the Company has decided that the Annual General Meeting will only be held by postal voting in accordance with the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. This means that the Annual General Meeting will be held without the presence of shareholders, proxies and outsiders, i.e. there will be no meeting with the opportunity to participate physically.
A digital postal voting form is available via the poströsta.se service: https://postrosta.web.verified.eu/?source=sprintbioscience. Physical shareholders or, where applicable, authorised representatives of shareholders who are legal entities, identify themselves when submitting the postal vote with BankID or another secure signing solution (detailed instructions, conditions and instructions for the postal vote are set out in the form). The postal voting form must be completed and signed no later than Tuesday 11 May 2021 and submitted to the Company via the above-mentioned web link.
A postal vote can be withdrawn until 11 May 2021 by sending an email to support@postrosta.se. If two or more forms have the same date, only the form received last will be considered.
The shareholder cannot give instructions other than to tick one of the response options at each point of the form. If the shareholder has provided the form with special instructions or conditions, or has changed or added to the pre-printed text, the postal vote is invalid. Further instructions are provided in the postal voting form.
Shareholders who vote by proxy must issue a dated power of attorney for the proxy. If the power of attorney is issued by a legal entity, a certified copy of the registration certificate or equivalent authorisation documents showing the authorised signatory must be attached. The power of attorney is valid for one year from the date of issue, but may be valid for up to five years from the date of issue if this is specifically stated. The registration certificate may not be older than one year. The proxy form and any registration certificate must be uploaded in connection with the digital postal voting form. Proxy forms are available on the Company's website, www.sprintbioscience.com.
For questions about the Annual General Meeting, please contact the Company by post to Sprint Bioscience AB (publ), Novum, Hälsovägen 7, 141 57 Huddinge or send an e-mail to info@sprintbioscience.com.